The long term goal of this research is the development of a plasmid DNA delivery alternative that will increase the effectiveness of gene therapy with plasmids. In the past, the combination of electric pulses with a nonpermeant drug such as bleomycin, eletrochemotherapy, has been an effective localized treatment for various cancers. The success of this technique may be due to increased drug uptake which is directly related to the physiological effects of the electric field (increased membrane permeability). Since electroporation has shown promise as a delivery method for hydrophilic drugs, it should also effectively deliver DNA in vivo. It is important to establish electrical parameters which can maximize DNA delivery and consequent gene expression, as well as to establish a highly reproducible technique. This will be determined by completing the following specific aims: i) to establish the range of electrical field strength and pulse width that will yield maximum expression of genes delivered in vivo directly to the skin; ii) to establish the plasmid concentration that will yield maximum expression of genes delivered in vivo directly to the skin; iii) to determine the time that maximal expression levels can be maintained and if this time can be increased by performing multiple delivery procedures. The work will be performed using C57B1/6 mice The first set of experiments will determine the electric field doses that generate maximal DNA delivery, as measured by reporter gene expression, to skin. One these electrical parameters are established, a plasmid DNA concentration gradient will be performed to determine the DNA concentration for maximal expression. Finally, repeated treatments to maintain long term gene expression will be explored. With this information, in vivo electroporation will be an effective method for plasmid DNA delivery.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21DK055588-01A1
Application #
6041283
Study Section
Special Emphasis Panel (ZRG1-SSS-X (16))
Program Officer
Mckeon, Catherine T
Project Start
2000-01-15
Project End
2001-12-31
Budget Start
2000-01-15
Budget End
2000-12-31
Support Year
1
Fiscal Year
2000
Total Cost
$143,521
Indirect Cost
Name
University of South Florida
Department
Surgery
Type
Schools of Medicine
DUNS #
069687242
City
Tampa
State
FL
Country
United States
Zip Code
33612
Heller, Richard; Cruz, Yolmari; Heller, Loree C et al. (2010) Electrically mediated delivery of plasmid DNA to the skin, using a multielectrode array. Hum Gene Ther 21:357-62
Heller, Loree C; Jaroszeski, Mark J; Coppola, Domenico et al. (2008) Comparison of electrically mediated and liposome-complexed plasmid DNA delivery to the skin. Genet Vaccines Ther 6:16
Heller, L C; Jaroszeski, M J; Coppola, D et al. (2007) Optimization of cutaneous electrically mediated plasmid DNA delivery using novel electrode. Gene Ther 14:275-80
Lucas, M L; Jaroszeski, M J; Gilbert, R et al. (2001) In vivo electroporation using an exponentially enhanced pulse: a new waveform. DNA Cell Biol 20:183-8